{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T14:54:05Z","timestamp":1648824845953},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/mpa.0000000000000348","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T13:21:00Z","timestamp":1429795260000},"page":"937-944","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Value of Excision Repair Cross-Complementing Gene 1, Dihydropyrimidine Dehydrogenase, and Human Equilibrative Nucleotide Transporter 1 Expression and Their Implications for Adjuvant Treatment in Patients With Ampullary Carcinoma"],"prefix":"10.1097","volume":"44","author":[{"given":"Yasunari","family":"Kawabata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Kidani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitsugu","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210212","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/01.sla.0000167853.04171.bb","article-title":"Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy.","volume":"242","author":"Yoon","year":"2005","journal-title":"Ann Surg"},{"key":"R2-13-20210212","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000286839","article-title":"Gross appearance of the ampullary tumor predicts lymph node metastasis and outcome.","volume":"27","author":"Kayahara","year":"2010","journal-title":"Dig Surg"},{"key":"R3-13-20210212","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2012.7352","article-title":"Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.","volume":"308","author":"Neoptolemos","year":"2012","journal-title":"JAMA"},{"key":"R4-13-20210212","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"R5-13-20210212","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.bjc.6605779","article-title":"Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan.","volume":"103","author":"Okusaka","year":"2010","journal-title":"Br J Cancer"},{"key":"R7-13-20210212","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1158\/0008-5472.CAN-05-4203","article-title":"Transcription analysis of human equilibrative nucleotide transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.","volume":"66","author":"Giovannetti","year":"2006","journal-title":"Cancer Res"},{"key":"R8-13-20210212","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ctrv.2007.07.001","article-title":"Current status of excision repair cross complementing-group 1 (ERCC1) in cancer.","volume":"33","author":"Gossage","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"R9-13-20210212","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","article-title":"Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.","volume":"357","author":"Sakuramoto","year":"2007","journal-title":"N Engl J Med"},{"key":"R10-13-20210212","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.canlet.2003.09.030","article-title":"Tumor dihydropyrimidine dehydrogenase in stage II and III colorectal cancer: low level expression is a beneficial marker in oral-adjuvant chemotherapy, but is also a predictor for poor prognosis in patients treated with curative surgery alone.","volume":"204","author":"Tsuji","year":"2004","journal-title":"Cancer Lett"},{"key":"R12-13-20210212","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1746-1596-5-75","article-title":"Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: correlation with tumor progression and prognosis.","volume":"5","author":"Kawabata","year":"2010","journal-title":"Diagn Pathol"},{"key":"R14-13-20210212","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1245\/s10434-011-1610-x","article-title":"Differential expression of ERCC1 in pancreas adenocarcinoma: high tumor expression is associated with earlier recurrence and shortened survival after resection.","volume":"18","author":"Maithel","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R15-13-20210212","doi-asserted-by":"crossref","first-page":"S646","DOI":"10.1245\/s10434-011-2140-2","article-title":"Combined analysis of dihydropyrimidine dehydrogenase and human equilibrative nucleotide transporter 1 expression predicts survival of pancreatic carcinoma patients treated with adjuvant gemcitabine plus S-1 chemotherapy after surgical resection.","volume":"19","author":"Kondo","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R16-13-20210212","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00534-011-0440-3","article-title":"Human equilibrative nucleotide transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy.","volume":"19","author":"Murata","year":"2012","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R17-13-20210212","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11605-009-1080-7","article-title":"Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis.","volume":"14","author":"Winter","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"R18-13-20210212","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00268-006-0213-3","article-title":"Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection.","volume":"31","author":"Qiao","year":"2007","journal-title":"World J Surg"},{"key":"R19-13-20210212","first-page":"177","article-title":"The relationship between survival and the expression of dihydropyrimidine dehydrogenase in patients with colorectal cancer.","volume":"16","author":"Hotta","year":"2006","journal-title":"Oncol Rep"},{"key":"R20-13-20210212","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1200\/JCO.2000.18.23.3946","article-title":"Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer.","volume":"18","author":"Fujiwaki","year":"2000","journal-title":"J Clin Oncol"},{"key":"R21-13-20210212","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10147-009-0008-2","article-title":"Clinical significance of dihydropyrimidine dehydrogenase and thymidylate synthase expression in patients with pancreatic cancer.","volume":"15","author":"Nakahara","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"R22-13-20210212","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0959-8049(00)00440-8","article-title":"The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer.","volume":"37","author":"Mizutani","year":"2001","journal-title":"Eur J Cancer"},{"key":"R23-13-20210212","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.oraloncology.2004.06.003","article-title":"Dihydropyrimidine dehydrogenase expression predicts survival outcome and chemosensitivity to 5-fluorouracil in patients with oral squamous cell carcinoma.","volume":"41","author":"Kobayashi","year":"2005","journal-title":"Oral Oncol"},{"key":"R24-13-20210212","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1200\/JCO.1995.13.7.1663","article-title":"Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.","volume":"13","author":"Etienne","year":"1995","journal-title":"J Clin Oncol"},{"key":"R25-13-20210212","first-page":"1322","article-title":"Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.","volume":"6","author":"Salonga","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R26-13-20210212","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1200\/JCO.1998.16.1.309","article-title":"ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.","volume":"16","author":"Metzger","year":"1998","journal-title":"J Clin Oncol"},{"key":"R27-13-20210212","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1200\/JCO.2001.19.23.4298","article-title":"ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy.","volume":"19","author":"Shirota","year":"2001","journal-title":"J Clin Oncol"},{"key":"R28-13-20210212","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/bjc.2012.502","article-title":"Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer.","volume":"107","author":"Baba","year":"2012","journal-title":"Br J Cancer"},{"key":"R29-13-20210212","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/j.gastro.2013.05.010","article-title":"Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.","volume":"145","author":"Lei","year":"2013","journal-title":"Gastroentelorogy"},{"key":"R30-13-20210212","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1136\/gut.2010.232272","article-title":"Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes.","volume":"60","author":"Mino-Kenudson","year":"2011","journal-title":"Gut"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000000348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:37:19Z","timestamp":1620963439000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201508000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000000348","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}